Dr Vietheer is a molecular virologist with a background in hepatitis viruses and vaccine development. Her current research focuses on hepatitis C virus and the development and pre-clinical evaluation of a vaccine candidate.
After completing her Bachelor of Science with Honours degree at University of Queensland, Dr Vietheer then undertook a Research Assistant position at the Institute of Molecular BioSciences in Brisbane with Dr Tom Loy working on the identification of human endogenous retroviruses in ancient human remains including 200 year-old Hungarian mummified tissue.
In 2002, Dr Vietheer joined the hepatitis B virus team at Sir Albert Sakzewski Virus Research Centre in Queensland as a Research Assistant lead by Associate Professor Hans Netter. Dr Vietheer helped to relocate Associate Professor Netter’s laboratory to Monash University in Victoria where she commenced her PhD in 2003.
In February 2007, Dr Vietheer joined Associate Professor Heidi Drummer’s laboratory at the Burnet Institute working on the development of a hepatitis C virus vaccine candidate. Dr Vietheer is also an Adjunct Lecturer in the Department of Microbiology at Monash University.
- Adjunct Lecturer, Department of Microbiology, Monash University
- 2015-present: General Manager, Business Development & Innovation, Burnet Institute
- 2010-present: Postdoctoral Fellow, Burnet Institute, Victoria, Australia
- 2007-2010: Postdoctoral Scientist, Burnet Institute, Victoria, Australia
- 2002: Research Assistant, Sir Albert Sakzewski Virus Research Centre, Queensland, Australia
- 2001: Research Assistant, Institute of Molecular BioSciences, Queensland, Australia
- 2007: PhD, Monash University, Australia
- 2000: BSc (Hons), University of Queensland, Australia
- 1999: BSc, University of Queensland, Australia
- 2013: Fresh Science State Finalist
- 2008: Australian Centre for HIV & Hepatitis Virology Young Investigator’s Award
- 2007: Australian Defence Force Prince of Wales Award
- 2006: 13th International Meeting on Hepatitis C and related viruses travel award
- 2003: NHMRC Dora Lush Biomedical Scholarship
- Escape of Hepatitis C virus from epitope I neutralization increases sensitivity of other neutralization epitopes.
Gu J, Hardy J, Boo I, Vietheer P, McCaffrey K, Alhammad Y, Chopra A, Gaudieri S, Poumbourios P, Coulibaly F, Drummer HE
J Virol. 2018 Feb; 92(9):e02066-17
- The core domain of hepatitis C virus glycoprotein E2 generates potent cross-neutralizing antibodies.
Vietheer P, Boo I, Gu J, McCaffrey K, Edwards S, Owczarek C, Hardy MP, Fabri L, Center RJ, Poumbourios P, Drummer HE
Hepatol. 2017 Jan; Epub ahead of print
- Monoclonal antibodies directed towards the Hepatitis C virus glycoprotein E2 detect antigenic differences modulated by HVR1, HVR2 and the igVR.
Alhammad Y, Gu J, Boo I, Harrison D, McCaffrey K, Vietheer PT, Edwards S, Quinn C, Coulibaly F, Poumbourios P, Drummer HE
J Virol. 2015 Sep; 89(24):12245-12261
News Articles (7)